Blood-brain barrier: Structural components and function under physiologic and pathologic conditions

Yuri Persidsky, Servio H. Ramirez, James Haorah, Georgette D. Kanmogne

Research output: Contribution to journalArticle

488 Citations (Scopus)

Abstract

The blood-brain barrier (BBB) is the specialized system of brain microvascular endothelial cells (BMVEC) that shields the brain from toxic substances in the blood, supplies brain tissues with nutrients, and filters harmful compounds from the brain back to the bloodstream. The close interaction between BMVEC and other components of the neurovascular unit (astrocytes, pericytes, neurons, and basement membrane) ensures proper function of the central nervous system (CNS). Transport across the BBB is strictly limited through both physical (tight junctions) and metabolic barriers (enzymes, diverse transport systems). A functional polarity exists between the luminal and abluminal membrane surfaces of the BMVEC. As a result of restricted permeability, the BBB is a limiting factor for the delivery of therapeutic agents into the CNS. BBB breakdown or alterations in transport systems play an important role in the pathogenesis of many CNS diseases (HIV-1 encephalitis, Alzheimer's disease, ischemia, tumors, multiple sclerosis, and Parkinson's disease). Proinflammatory substances and specific disease-associated proteins often mediate such BBB dysfunction. Despite seemingly diverse underlying causes of BBB dysfunction, common intracellular pathways emerge for the regulation of the BBB structural and functional integrity. Better understanding of tight junction regulation and factors affecting transport systems will allow the development of therapeutics to improve the BBB function in health and disease.

Original languageEnglish (US)
Pages (from-to)223-236
Number of pages14
JournalJournal of Neuroimmune Pharmacology
Volume1
Issue number3
DOIs
StatePublished - Sep 1 2006

Fingerprint

Blood-Brain Barrier
Brain
Endothelial Cells
Tight Junctions
Central Nervous System Agents
Pericytes
Poisons
Central Nervous System Diseases
Encephalitis
Cellular Structures
Basement Membrane
Astrocytes
Multiple Sclerosis
Parkinson Disease
HIV-1
Permeability
Alzheimer Disease
Ischemia
Central Nervous System
Neurons

All Science Journal Classification (ASJC) codes

  • Neuroscience (miscellaneous)
  • Immunology and Allergy
  • Pharmacology
  • Immunology

Keywords

  • Blood-brain barrier
  • Leukocyte migration
  • Multidrug resistance proteins
  • Neurovascular unit
  • Tight junctions

Cite this

Persidsky, Yuri ; Ramirez, Servio H. ; Haorah, James ; Kanmogne, Georgette D. / Blood-brain barrier : Structural components and function under physiologic and pathologic conditions. In: Journal of Neuroimmune Pharmacology. 2006 ; Vol. 1, No. 3. pp. 223-236.
@article{7b0f3d26e9ae447f8961cfeb10dfcd8e,
title = "Blood-brain barrier: Structural components and function under physiologic and pathologic conditions",
abstract = "The blood-brain barrier (BBB) is the specialized system of brain microvascular endothelial cells (BMVEC) that shields the brain from toxic substances in the blood, supplies brain tissues with nutrients, and filters harmful compounds from the brain back to the bloodstream. The close interaction between BMVEC and other components of the neurovascular unit (astrocytes, pericytes, neurons, and basement membrane) ensures proper function of the central nervous system (CNS). Transport across the BBB is strictly limited through both physical (tight junctions) and metabolic barriers (enzymes, diverse transport systems). A functional polarity exists between the luminal and abluminal membrane surfaces of the BMVEC. As a result of restricted permeability, the BBB is a limiting factor for the delivery of therapeutic agents into the CNS. BBB breakdown or alterations in transport systems play an important role in the pathogenesis of many CNS diseases (HIV-1 encephalitis, Alzheimer's disease, ischemia, tumors, multiple sclerosis, and Parkinson's disease). Proinflammatory substances and specific disease-associated proteins often mediate such BBB dysfunction. Despite seemingly diverse underlying causes of BBB dysfunction, common intracellular pathways emerge for the regulation of the BBB structural and functional integrity. Better understanding of tight junction regulation and factors affecting transport systems will allow the development of therapeutics to improve the BBB function in health and disease.",
keywords = "Blood-brain barrier, Leukocyte migration, Multidrug resistance proteins, Neurovascular unit, Tight junctions",
author = "Yuri Persidsky and Ramirez, {Servio H.} and James Haorah and Kanmogne, {Georgette D.}",
year = "2006",
month = "9",
day = "1",
doi = "https://doi.org/10.1007/s11481-006-9025-3",
language = "English (US)",
volume = "1",
pages = "223--236",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "3",

}

Blood-brain barrier : Structural components and function under physiologic and pathologic conditions. / Persidsky, Yuri; Ramirez, Servio H.; Haorah, James; Kanmogne, Georgette D.

In: Journal of Neuroimmune Pharmacology, Vol. 1, No. 3, 01.09.2006, p. 223-236.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Blood-brain barrier

T2 - Structural components and function under physiologic and pathologic conditions

AU - Persidsky, Yuri

AU - Ramirez, Servio H.

AU - Haorah, James

AU - Kanmogne, Georgette D.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - The blood-brain barrier (BBB) is the specialized system of brain microvascular endothelial cells (BMVEC) that shields the brain from toxic substances in the blood, supplies brain tissues with nutrients, and filters harmful compounds from the brain back to the bloodstream. The close interaction between BMVEC and other components of the neurovascular unit (astrocytes, pericytes, neurons, and basement membrane) ensures proper function of the central nervous system (CNS). Transport across the BBB is strictly limited through both physical (tight junctions) and metabolic barriers (enzymes, diverse transport systems). A functional polarity exists between the luminal and abluminal membrane surfaces of the BMVEC. As a result of restricted permeability, the BBB is a limiting factor for the delivery of therapeutic agents into the CNS. BBB breakdown or alterations in transport systems play an important role in the pathogenesis of many CNS diseases (HIV-1 encephalitis, Alzheimer's disease, ischemia, tumors, multiple sclerosis, and Parkinson's disease). Proinflammatory substances and specific disease-associated proteins often mediate such BBB dysfunction. Despite seemingly diverse underlying causes of BBB dysfunction, common intracellular pathways emerge for the regulation of the BBB structural and functional integrity. Better understanding of tight junction regulation and factors affecting transport systems will allow the development of therapeutics to improve the BBB function in health and disease.

AB - The blood-brain barrier (BBB) is the specialized system of brain microvascular endothelial cells (BMVEC) that shields the brain from toxic substances in the blood, supplies brain tissues with nutrients, and filters harmful compounds from the brain back to the bloodstream. The close interaction between BMVEC and other components of the neurovascular unit (astrocytes, pericytes, neurons, and basement membrane) ensures proper function of the central nervous system (CNS). Transport across the BBB is strictly limited through both physical (tight junctions) and metabolic barriers (enzymes, diverse transport systems). A functional polarity exists between the luminal and abluminal membrane surfaces of the BMVEC. As a result of restricted permeability, the BBB is a limiting factor for the delivery of therapeutic agents into the CNS. BBB breakdown or alterations in transport systems play an important role in the pathogenesis of many CNS diseases (HIV-1 encephalitis, Alzheimer's disease, ischemia, tumors, multiple sclerosis, and Parkinson's disease). Proinflammatory substances and specific disease-associated proteins often mediate such BBB dysfunction. Despite seemingly diverse underlying causes of BBB dysfunction, common intracellular pathways emerge for the regulation of the BBB structural and functional integrity. Better understanding of tight junction regulation and factors affecting transport systems will allow the development of therapeutics to improve the BBB function in health and disease.

KW - Blood-brain barrier

KW - Leukocyte migration

KW - Multidrug resistance proteins

KW - Neurovascular unit

KW - Tight junctions

UR - http://www.scopus.com/inward/record.url?scp=33747368249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747368249&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/s11481-006-9025-3

DO - https://doi.org/10.1007/s11481-006-9025-3

M3 - Article

C2 - 18040800

VL - 1

SP - 223

EP - 236

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

SN - 1557-1890

IS - 3

ER -